Adolescents with atopic dermatitis experience a higher prevalence and a higher frequency of bullying compared with their peers who do not have atopic dermatitis, according to the results of a new ...

Please provide your email address to receive an email when new articles are posted on . MIAMI BEACH, Fla. — Social media may contribute to the high rates of mental health problems and disorders among ...

Adolescents with AD experience higher emotional distress, while younger children face more sleep disturbances and itching-related issues. The study emphasizes the need for age-specific treatment ...

Please provide your email address to receive an email when new articles are posted on . Oral abrocitinib, in combination with topical therapy, was effective and well tolerated in the treatment of ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the international CorEvitas Adolescent Atopic Dermatitis (AD) ...

Children and adolescents with atopic dermatitis (AD) tended to have a higher number of delinquent behaviors than those without AD, including fighting, cheating on exams, and suspension. Incidence of ...

Dermatitis Asthma Atopic Disease The approval was based on data from previous studies that included 124 adolescent patients, as well as the phase 3 JADE TEEN study. The Food and Drug Administration ...

BALLERUP, Denmark & MADISON, N.J.--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, today announced 16-week results of a 52-week monotherapy trial showing tralokinumab ...

ZORYVE cream, 0.15%, is indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 6 years of age and older. IMPORTANT SAFETY INFORMATION ZORYVE is ...

Adolescents with AD have reported appearance-based bullying. To evaluate the association between AD and the prevalence and frequency of bullying, researchers analyzed cross-sectional data from adult ...

Atopic dermatitis, the most common form of eczema, affects millions of Americans with its hallmark symptoms of dry, itchy, and inflamed skin. While this chronic condition can impact individuals across ...

TARRYTOWN, N.Y. and PARIS, June 07, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today presented results from the DISCOVER Phase 4, single-arm, open-label trial ...